Pharmaceutical drug prices and trends for ISOSORBIDE MONONIT ER

Subscribe to access the full database, or Try for Free
Drug Name	NDC	Price/Unit ($)	Unit	Date
ISOSORBIDE MONONIT ER 30 MG TB	00904-6449-61	0.07349	EACH	2025-03-19
ISOSORBIDE MONONIT ER 120 MG	50742-0177-01	0.17203	EACH	2025-03-19
ISOSORBIDE MONONIT ER 120 MG	62135-0588-90	0.17203	EACH	2025-03-19
ISOSORBIDE MONONIT ER 120 MG	13668-0106-01	0.17203	EACH	2025-03-19
ISOSORBIDE MONONIT ER 120 MG	59651-0541-01	0.17203	EACH	2025-03-19
ISOSORBIDE MONONIT ER 120 MG	23155-0628-01	0.17203	EACH	2025-03-19
ISOSORBIDE MONONIT ER 120 MG	42799-0960-01	0.17203	EACH	2025-03-19
>Drug Name	>NDC	>Price/Unit ($)	>Unit	>Date

Market Overview

Isosorbide mononitrate (ISMN) is a crucial medication in the treatment of angina pectoris and other cardiovascular conditions. The market for ISMN is experiencing significant growth driven by several key factors.

Market Size and Growth Potential

The ISMN market was valued at USD 400 million in 2023 and is projected to reach USD 700 million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 5.7% during the forecast period of 2024-2030[1].

Market Drivers

Cardiovascular Disease Prevalence

The increasing prevalence of cardiovascular diseases worldwide is a major driver for the ISMN market. As coronary artery disease and angina pectoris become more common, the demand for ISMN and other antianginal agents rises[1].

Growing Aging Population

The aging population is another significant factor. As people age, the incidence of cardiovascular illnesses increases, thereby boosting the demand for ISMN[1].

Growing Healthcare Expenditure

Increased healthcare spending in both developed and developing countries enhances access to pharmaceuticals like ISMN, contributing to market growth[1].

Drug Delivery System Advancements

Advancements in drug delivery systems, such as extended-release formulations of ISMN, improve patient compliance and efficacy, further propelling the market[1].

Government Programs and Healthcare Policies

Government initiatives that improve access to pharmaceuticals, enhance healthcare infrastructure, and raise awareness about cardiovascular diseases also support the growth of the ISMN market[1].

Market Restraints

Availability of Substitute Drugs

The presence of alternative treatments such as beta-blockers, calcium channel blockers, and surgical procedures can limit the market expansion of ISMN[1].

Drug Interactions

Potential harmful interactions with other medications, particularly those used for erectile dysfunction, can restrict the use of ISMN in certain patient populations[1].

Limited Clinical Evidence

Insufficient clinical evidence supporting the effectiveness of ISMN in specific patient populations or clinical scenarios can impact market demand and prescribing practices[1].

Market Segmentation

By Formulation

The ISMN market is segmented into immediate-release and extended-release tablets. Extended-release formulations are particularly popular due to their improved patient compliance and efficacy[1].

By Indication

ISMN is primarily used for treating angina pectoris but is also used for other cardiovascular conditions. The market is driven largely by the demand for angina treatment[1].

By Distribution Channel

The market is segmented into hospital pharmacies, retail/community pharmacies, and online pharmacies. Retail pharmacies remain a significant distribution channel due to their widespread presence and convenience[1].

Regional Analysis

North America

North America holds the largest market share due to the high prevalence of cardiovascular diseases and advanced healthcare infrastructure. The United States, Canada, and Mexico are key markets in this region[1].

Europe

Europe is the second-largest market, driven by an aging population and increased awareness of cardiovascular health. Countries like the United Kingdom, Germany, France, and Italy are significant contributors[1].

Asia-Pacific

The Asia-Pacific region is expected to grow at the highest rate, driven by a large population base and rapidly expanding economies. China, Japan, India, and Australia are key markets in this region[1].

Latin America and Middle East & Africa

These regions are also growing, with increasing healthcare spending and rising awareness of cardiovascular diseases. Brazil, Argentina, Chile, South Africa, and Saudi Arabia are notable markets[1].

Price Projections

Current Pricing

The cost of ISMN varies based on the formulation and dosage. For example, a 60 mg oral tablet, extended release, can cost around $14 for a supply of 30 tablets for cash-paying customers[2].

Generic vs. Branded

Generic versions of ISMN are available at significantly lower prices compared to branded versions like Imdur. For instance, Imdur 60 mg extended-release tablets can cost around $359 for 100 tablets, while generic ISMN can cost as low as $14.33 for 30 tablets[5].

Discounts and Patient Assistance

Discount cards and patient assistance programs can further reduce the cost of ISMN. For example, the Drugs.com Discount Card can save up to 80% on prescription medicines[2][5].

Technological and Manufacturing Developments

Advancements in Manufacturing

Technological developments in manufacturing processes can lead to more affordable production techniques, potentially lowering the overall cost of ISMN and increasing its accessibility[1].

Clinical Studies and Research

Ongoing clinical studies and research aimed at expanding the indications and commercial potential of ISMN can also impact market growth and pricing strategies[1].

Emerging Markets and Opportunities

Growing Demand in Emerging Markets

Emerging markets, particularly in rapidly urbanizing countries with improving healthcare facilities, offer significant growth opportunities for ISMN. These markets are driven by changing lifestyles and increasing awareness of cardiovascular health[1].

Bioplastics and Sustainable Materials

The growing demand for bio-based products and sustainable materials also presents opportunities for isosorbide derivatives, including ISMN, in various industrial applications[3][4].

Key Takeaways

The ISMN market is projected to grow significantly due to increasing cardiovascular disease prevalence, an aging population, and advancements in drug delivery systems.
The market is segmented by formulation, indication, and distribution channel, with extended-release formulations being particularly popular.
North America and Europe are major markets, but the Asia-Pacific region is expected to grow at the highest rate.
Generic versions of ISMN are available at lower prices compared to branded versions.
Technological developments and clinical studies are expected to further drive market growth.

FAQs

1. What is the primary use of Isosorbide Mononitrate (ISMN)?

ISMN is primarily used to treat angina pectoris, a symptom of coronary artery disease.

2. What is the projected market size of ISMN by 2030?

The ISMN market is projected to reach USD 700 million by 2030, growing at a CAGR of 5.7% during the forecast period of 2024-2030[1].

3. What are the main drivers of the ISMN market?

Key drivers include the increasing prevalence of cardiovascular diseases, an aging population, growing healthcare expenditure, advancements in drug delivery systems, and government healthcare policies[1].

4. How does the availability of generic ISMN impact the market?

The availability of generic ISMN increases market penetration by offering a more affordable alternative to branded versions, thus driving down prices and increasing accessibility[1].

5. What are the potential restraints on the ISMN market?

Significant restraints include the availability of substitute drugs, potential drug interactions, and limited clinical evidence supporting its effectiveness in certain patient populations[1].

Sources

Verified Market Research: Isosorbide Mononitrate Market Size, Share, Scope & Forecast.
Drugs.com: Isosorbide mononitrate Prices, Coupons, Copay Cards & Patient Assistance.
Mordor Intelligence: Isosorbide Market - Share, Size & Growth.
Research and Markets: Isosorbide Market Size, Competitors & Forecast to 2030.
Drugs.com: Imdur Prices, Coupons, Copay Cards & Patient Assistance.